USA flag logo/image

An Official Website of the United States Government

Therapy for gastrointestinal disorders

Award Information

Agency:
Department of Health and Human Services 		Branch:
N/A 		Award ID:
55861 		Program Year/Program:
2001 / STTR
Agency Tracking Number:
2R42DK055374-02A1 		Solicitation Year:
N/A 		Solicitation Topic Code:
N/A 		Solicitation Number:
N/A
Small Business Information
AGENNIX, INC.
AGENNIX, INC. 8 GREENWAY PLZ, STE 910 HOUSTON, TX 77046 0892
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: Yes
 
Phase 1
Fiscal Year: 2001
Title: Therapy for gastrointestinal disorders
Agency: HHS
Contract: PHS2001-2
Award Amount: $0.00
 

Abstract:

DESCRIPTION (Applicant's Abstract): The overall goal of this research proposal is to determine the effectiveness of recombinant human lactoferrin (rhLF) for treating gastrointestinal (GI) disorders. This Phase II proposal will focus on the ability of rhLF to treat the 01 side effects of non-steroidal anti-inflammatory drugs (NSAIDs), a class of drugs widely-used for reduction of pain, fever, and inflammation. The adverse GI side effects of ulceration and bleeding limit the usefulness of NSAIDs. Recombinant human lactoferrin, produced in high purity by advanced technological means, has a unique combination of antibiotic, anti-inflammatory. and mucosal healing properties that make it especially useful for the reduction of NSAID toxicity. The specific aims of this proposal are to use animal models to determine: 1) the efficacy of rhLF to prevent acute and chronic NSAID-induced GI side effects; 2) the ability of rhLF to heal GI lesions that are aggravated by NSAIDs; and 3) the mechanism for rhLF protection of the 0! tract in the presence of NSAIDs. Development of this therapeutic potential for rhLF will fulfill a crucial need for a way to safely administer NSAIDs. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Principal Investigator:

Elizabeth J. Dial
7135006318
ELIZABETH.J.DIAL@UTH.TMC.EDU

Business Contact:

Headon, denis r.
7135521091
DHEADON@AGENNIX.COM
Small Business Information at Submission:

AGENNIX, INC.
8 GREENWAY PLAZA, STE 710 HOUSTON, TX 77046 HOUSTON, TX 77046

EIN/Tax ID: 954405779
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER
HOUSTON, TX 77225
RI Type: Nonprofit college or university